We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.21B
AUM Growth
+$110M
Cap. Flow
-$79.3M
Cap. Flow %
-3.59%
Top 10 Hldgs %
22.7%
Holding
3,121
New
66
Increased
341
Reduced
717
Closed
30

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$3.73M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$3.01M
3
COP icon
ConocoPhillips
COP
+$2.6M
4
NOW icon
ServiceNow
NOW
+$1.95M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.95M

Top Sells

Rank Stock Value
1
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.14M
2
MSFT icon
Microsoft
MSFT
+$4.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$3.96M
4
TER icon
Teradyne
TER
+$3.85M
5
ETSY icon
Etsy
ETSY
+$3.81M

Sector Composition

Rank Sector Weight
1 Technology 17.76%
2 Consumer Discretionary 10.46%
3 Healthcare 9.6%
4 Financials 9.53%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMAT icon
1926
LeMaitre Vascular
LMAT
$1.87B
$42K ﹤0.01%
1,302
– –
NKTX icon
1927
Nkarta
NKTX
$165M
$42K ﹤0.01%
+1,385
New +$40.8K
RIG icon
1928
Transocean
RIG
$6.39B
$42K ﹤0.01%
51,662
-162,611
-76% -$266K
UMH
1929
UMH Properties
UMH
$1.42B
$42K ﹤0.01%
3,128
– –
VREX icon
1930
Varex Imaging
VREX
$780M
$42K ﹤0.01%
3,308
– –
KLRS
1931
Kalaris Therapeutics
KLRS
$92.4M
$42K ﹤0.01%
+66
New +$45.1K
TVRD
1932
Tvardi Therapeutics
TVRD
$22.1M
$42K ﹤0.01%
92
– –
AERI
1933
DELISTED
Aerie Pharmaceuticals
AERI
$42K ﹤0.01%
3,606
– –
ASMB icon
1934
Assembly Biosciences
ASMB
$594M
$41K ﹤0.01%
206
– –
BBT
1935
Beacon Financial Corp
BBT
$2.71B
$41K ﹤0.01%
4,064
– –
BSCS icon
1936
Invesco BulletShares 2028 Corporate Bond ETF
BSCS
$3.59B
$41K ﹤0.01%
1,802
+552
+44% +$12.8K
BTAI icon
1937
BioXcel Therapeutics
BTAI
$34.9M
$41K ﹤0.01%
58
– –
FFWM
1938
DELISTED
First Foundation Inc
FFWM
$41K ﹤0.01%
3,136
– –
GRPN icon
1939
Groupon
GRPN
$894M
$41K ﹤0.01%
2,006
– –
IWN icon
1940
iShares Russell 2000 Value ETF
IWN
$14.7B
$41K ﹤0.01%
418
+175
+72% +$17.8K
KRRO icon
1941
Korro Bio
KRRO
$196M
$41K ﹤0.01%
43
-7
-14% -$7.51K
MYE icon
1942
Myers Industries
MYE
$1.25B
$41K ﹤0.01%
3,117
– –
NAT icon
1943
Nordic American Tanker
NAT
$1.4B
$41K ﹤0.01%
11,683
– –
ROAD icon
1944
Construction Partners
ROAD
$6.73B
$41K ﹤0.01%
2,244
+729
+48% +$13.1K
RSPT icon
1945
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$6.05B
$41K ﹤0.01%
1,990
– –
SCSC icon
1946
Scansource
SCSC
$1.06B
$41K ﹤0.01%
2,089
– –
TRST
1947
Trustco Bank Corp NY
TRST
$971M
$41K ﹤0.01%
1,565
– –
VNDA icon
1948
Vanda Pharmaceuticals
VNDA
$304M
$41K ﹤0.01%
4,281
– –
CAI
1949
DELISTED
CAI International, Inc.
CAI
$41K ﹤0.01%
1,481
– –
COWN
1950
DELISTED
Cowen Inc. Class A Common Stock
COWN
$41K ﹤0.01%
2,526
– –
76 77
78
79 80

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

Ameritas Investment Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Ameritas Investment Partners held 3,121 positions worth $2.21B, up 5.2% from $2.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ameritas Investment Partners withdrew a net $79.3M in Q3 2020, closing 30 positions and reducing 717 holdings. Its most notable exit was Caesars Entertainment Corporation, an estimated $1.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Ameritas Investment Partners opened a new position in Jazz Pharmaceuticals worth $2.24M.

  • Ameritas Investment Partners's largest Q3 2020 buy was Jazz Pharmaceuticals: 15,701 shares worth $2.24M.
  • Ameritas Investment Partners added most to Invesco QQQ Trust in Q3 2020, an estimated $3.73M increase.
  • Ameritas Investment Partners's biggest Q3 2020 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $6.14M.
  • Ameritas Investment Partners fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $1.97M.
  • Ameritas Investment Partners's ten largest holdings make up 23% of its $2.21B portfolio in Q3 2020.
  • Ameritas Investment Partners opened 66 new positions and closed 30 in Q3 2020.
  • Ameritas Investment Partners's portfolio value rose 5.2% quarter-over-quarter to $2.21B.

Based on Ameritas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.